These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12729946)

  • 1. Chronic lithium and sodium valproate both decrease the concentration of myoinositol and increase the concentration of inositol monophosphates in rat brain.
    O'Donnell T; Rotzinger S; Nakashima TT; Hanstock CC; Ulrich M; Silverstone PH
    Eur Neuropsychopharmacol; 2003 May; 13(3):199-207. PubMed ID: 12729946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain.
    O'Donnell T; Rotzinger S; Nakashima TT; Hanstock CC; Ulrich M; Silverstone PH
    Brain Res; 2000 Oct; 880(1-2):84-91. PubMed ID: 11032992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myo-inositol.
    McGrath BM; Greenshaw AJ; McKay R; Slupsky CM; Silverstone PH
    Neuroreport; 2007 Oct; 18(15):1595-8. PubMed ID: 17885608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients.
    Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC
    Int Clin Psychopharmacol; 2003 Mar; 18(2):73-9. PubMed ID: 12598817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients.
    Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC
    Hum Psychopharmacol; 2002 Oct; 17(7):321-7. PubMed ID: 12415549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation.
    Bell EC; Willson MC; Wilman AH; Dave S; Asghar SJ; Silverstone PH
    Hum Psychopharmacol; 2005 Mar; 20(2):87-96. PubMed ID: 15651051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate attenuates dextroamphetamine-induced subjective changes more than lithium.
    Willson MC; Bell EC; Dave S; Asghar SJ; McGrath BM; Silverstone PH
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):633-9. PubMed ID: 15949922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lithium and amphetamine on inositol metabolism in the human brain as measured by 1H and 31P MRS.
    Silverstone PH; Rotzinger S; Pukhovsky A; Hanstock CC
    Biol Psychiatry; 1999 Dec; 46(12):1634-41. PubMed ID: 10624544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium and valproate and their possible effects on themyo-inositol second messenger system in healthy volunteers and bipolar patients.
    Silverstone PH; McGrath BM
    Int Rev Psychiatry; 2009; 21(4):414-23. PubMed ID: 20374155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates.
    Dixon JF; Hokin LE
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4757-60. PubMed ID: 9114064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic lithium and sodium valproate on concentrations of brain amino acids.
    O'Donnell T; Rotzinger S; Ulrich M; Hanstock CC; Nakashima TT; Silverstone PH
    Eur Neuropsychopharmacol; 2003 Aug; 13(4):220-7. PubMed ID: 12888180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral lithium, inositol and inositol monophosphates.
    Hirvonen MR
    Pharmacol Toxicol; 1991 Jul; 69(1):22-7. PubMed ID: 1658767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients.
    Silverstone PH; Asghar SJ; O'Donnell T; Ulrich M; Hanstock CC
    World J Biol Psychiatry; 2004 Jan; 5(1):38-44. PubMed ID: 15048634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate decreases inositol biosynthesis.
    Shaltiel G; Shamir A; Shapiro J; Ding D; Dalton E; Bialer M; Harwood AJ; Belmaker RH; Greenberg ML; Agam G
    Biol Psychiatry; 2004 Dec; 56(11):868-74. PubMed ID: 15576064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
    Vadnal R; Parthasarathy R
    Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis.
    Vaden DL; Ding D; Peterson B; Greenberg ML
    J Biol Chem; 2001 May; 276(18):15466-71. PubMed ID: 11278273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dextro-amphetamine increases phosphoinositol cycle activity in volunteers: an MRS study.
    Silverstone PH; O'Donnell T; Ulrich M; Asghar S; Hanstock CC
    Hum Psychopharmacol; 2002 Dec; 17(8):425-9. PubMed ID: 12457379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?
    Rapoport SI; Bosetti F
    Arch Gen Psychiatry; 2002 Jul; 59(7):592-6. PubMed ID: 12090811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inositol, lithium, and the brain.
    Agranoff BW; Fisher SK
    Psychopharmacol Bull; 2001; 35(3):5-18. PubMed ID: 12397875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.